Evaluation of the ResistancePlus MG FleXible Cartridge for Near-Point-of-Care Testing of Mycoplasma genitalium and Associated Macrolide Resistance Mutations.
作者信息
Sweeney E L, Mhango L P, Ebeyan S, Tan L Y, Bletchly C, Nimmo G R, Whiley D M
机构信息
University of Queensland Centre for Clinical Research (UQ-CCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
University of Queensland Centre for Clinical Research (UQ-CCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
出版信息
J Clin Microbiol. 2020 Feb 24;58(3). doi: 10.1128/JCM.01897-19.
Abstract
摘要
相似文献
1
Evaluation of the ResistancePlus MG FleXible Cartridge for Near-Point-of-Care Testing of Mycoplasma genitalium and Associated Macrolide Resistance Mutations.
J Clin Microbiol. 2020 Feb 24;58(3). doi: 10.1128/JCM.01897-19.
2
Prospective Evaluation of ResistancePlus MG, a New Multiplex Quantitative PCR Assay for Detection of Mycoplasma genitalium and Macrolide Resistance.
J Clin Microbiol. 2017 Jun;55(6):1915-1919. doi: 10.1128/JCM.02312-16. Epub 2017 Apr 5.
3
Evaluation of ResistancePlus MG FleXible, a 'near-patient' test for the detection of and macrolide resistance mutations, using freshly collected clinical samples.
J Med Microbiol. 2021 Jan;70(1). doi: 10.1099/jmm.0.001271.
4
Clinical evaluation of the ResistancePlus MG FleXible test on the GeneXpert Infinity-48s instrument: a near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance.
Diagn Microbiol Infect Dis. 2020 Aug;97(4):115062. doi: 10.1016/j.diagmicrobio.2020.115062. Epub 2020 Apr 17.
5
Evaluation of the Resistance Plus kit for the detection of and mutations associated with macrolide resistance.
Sex Transm Infect. 2018 Dec;94(8):565-567. doi: 10.1136/sextrans-2017-053366. Epub 2017 Nov 3.
6
Clinical Evaluation of Three Commercial PCR Assays for the Detection of Macrolide Resistance in Mycoplasma genitalium.
J Clin Microbiol. 2020 Jan 28;58(2). doi: 10.1128/JCM.01478-19.
7
High Macrolide Resistance in Mycoplasma genitalium Strains Causing Infection in Auckland, New Zealand.
J Clin Microbiol. 2017 Jul;55(7):2280-2282. doi: 10.1128/JCM.00370-17. Epub 2017 May 3.
8
Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene.
Methods Mol Biol. 2012;903:129-39. doi: 10.1007/978-1-61779-937-2_8.
9
High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment.
J Antimicrob Chemother. 2015 Sep;70(9):2515-8. doi: 10.1093/jac/dkv136. Epub 2015 May 20.
10
Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany.
Diagn Microbiol Infect Dis. 2016 Oct;86(2):221-3. doi: 10.1016/j.diagmicrobio.2016.07.005. Epub 2016 Jul 8.
引用本文的文献
1
Treatment of bacterial sexually transmitted infections in Europe: gonorrhoea, , and syphilis.
Lancet Reg Health Eur. 2023 Oct 26;34:100737. doi: 10.1016/j.lanepe.2023.100737. eCollection 2023 Nov.
2
Latest Advances in Laboratory Detection of Mycoplasma genitalium.
J Clin Microbiol. 2023 Mar 23;61(3):e0079021. doi: 10.1128/jcm.00790-21. Epub 2023 Jan 4.
3
Clinical Performance of Three Commercial Molecular Diagnostic Assays for the Detection of Fluoroquinolone Resistance-Associated Mutations in Mycoplasma genitalium.
J Clin Microbiol. 2022 Dec 21;60(12):e0113522. doi: 10.1128/jcm.01135-22. Epub 2022 Nov 2.
4
Rapid Detection of Antimicrobial Resistance in Mycoplasma genitalium by High-Resolution Melting Analysis with Unlabeled Probes.
Microbiol Spectr. 2022 Aug 31;10(4):e0101422. doi: 10.1128/spectrum.01014-22. Epub 2022 Jul 26.
5
Bridging the gap between development of point-of-care nucleic acid testing and patient care for sexually transmitted infections.
Lab Chip. 2022 Feb 1;22(3):476-511. doi: 10.1039/d1lc00665g.
6
Performance of Three Commercial Molecular Diagnostic Assays for the Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance.
J Clin Microbiol. 2021 May 19;59(6). doi: 10.1128/JCM.00020-21.
7
Point-by-Point Progress: Gonorrhea Point of Care Tests.
Expert Rev Mol Diagn. 2020 Aug;20(8):803-813. doi: 10.1080/14737159.2020.1778467. Epub 2020 Jun 30.
本文引用的文献
1
Levels of Antimicrobial Resistance Differ by Both Region and Gender in the State of Queensland, Australia: Implications for Treatment Guidelines.
J Clin Microbiol. 2019 Feb 27;57(3). doi: 10.1128/JCM.01555-18. Print 2019 Mar.
2
Prevalence and antibiotic resistance of among STI clinic attendees in Western Canada: a cross-sectional analysis.
BMJ Open. 2017 Jul 10;7(7):e016300. doi: 10.1136/bmjopen-2017-016300.
3
Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany.
Diagn Microbiol Infect Dis. 2016 Oct;86(2):221-3. doi: 10.1016/j.diagmicrobio.2016.07.005. Epub 2016 Jul 8.
4
Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance.
Can Fam Physician. 2016 Feb;62(2):e96-101.
5
Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States.
J Clin Microbiol. 2016 Sep;54(9):2278-83. doi: 10.1128/JCM.01053-16. Epub 2016 Jun 15.
6
Drug resistance-associated mutations in Mycoplasma genitalium in female sex workers, Japan.
Emerg Infect Dis. 2015 Jun;21(6):1062-4. doi: 10.3201/eid2106.142013.
7
Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance.
Clin Infect Dis. 2008 Dec 15;47(12):1546-53. doi: 10.1086/593188.
8
Use of TaqMan 5' nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic.
J Clin Microbiol. 2004 Feb;42(2):683-92. doi: 10.1128/JCM.42.2.683-692.2004.
Zotero 插件